Dyrager C - Search Results

1

Multifunctional quinoline-triazole derivatives as potential modulators of amyloid-β peptide aggregation.

Jones MR, Dyrager C, Hoarau M, Korshavn KJ, Lim MH, Ramamoorthy A, Storr T. Jones MR, et al. Among authors: dyrager c. J Inorg Biochem. 2016 May;158:131-138. doi: 10.1016/j.jinorgbio.2016.04.022. Epub 2016 Apr 16. J Inorg Biochem. 2016. PMID: 27133802 No abstract available.

2

8-Hydroxyquinoline Schiff-base compounds as antioxidants and modulators of copper-mediated Aβ peptide aggregation.

Gomes LM, Vieira RP, Jones MR, Wang MC, Dyrager C, Souza-Fagundes EM, Da Silva JG, Storr T, Beraldo H. Gomes LM, et al. Among authors: dyrager c. J Inorg Biochem. 2014 Oct;139:106-16. doi: 10.1016/j.jinorgbio.2014.04.011. Epub 2014 Apr 28. J Inorg Biochem. 2014. PMID: 25019963

3

Multi-target-directed phenol-triazole ligands as therapeutic agents for Alzheimer's disease.

Jones MR, Mathieu E, Dyrager C, Faissner S, Vaillancourt Z, Korshavn KJ, Lim MH, Ramamoorthy A, Wee Yong V, Tsutsui S, Stys PK, Storr T. Jones MR, et al. Among authors: dyrager c. Chem Sci. 2017 Aug 1;8(8):5636-5643. doi: 10.1039/c7sc01269a. Epub 2017 Jun 5. Chem Sci. 2017. PMID: 28989601 Free PMC article.

4

Towards the development of chromone-based MEK1/2 modulators.

Redwan IN, Dyrager C, Solano C, Fernández de Trocóniz G, Voisin L, Bliman D, Meloche S, Grøtli M. Redwan IN, et al. Among authors: dyrager c. Eur J Med Chem. 2014 Oct 6;85:127-38. doi: 10.1016/j.ejmech.2014.07.018. Epub 2014 Jul 7. Eur J Med Chem. 2014. PMID: 25078316

5

Design, synthesis, and biological evaluation of chromone-based p38 MAP kinase inhibitors.

Dyrager C, Möllers LN, Kjäll LK, Alao JP, Dinér P, Wallner FK, Sunnerhagen P, Grøtli M. Dyrager C, et al. J Med Chem. 2011 Oct 27;54(20):7427-31. doi: 10.1021/jm200818j. Epub 2011 Sep 26. J Med Chem. 2011. PMID: 21905739

6

Chroman-4-one and chromone based somatostatin β-turn mimetics.

Fridén-Saxin M, Seifert T, Malo M, da Silva Andersson K, Pemberton N, Dyrager C, Friberg A, Dahlén K, Wallén EA, Grøtli M, Luthman K. Fridén-Saxin M, et al. Among authors: dyrager c. Eur J Med Chem. 2016 May 23;114:59-64. doi: 10.1016/j.ejmech.2016.02.046. Epub 2016 Feb 21. Eur J Med Chem. 2016. PMID: 26974375

7

Synthesis of 2-alkyl-substituted chromone derivatives using microwave irradiation.

Fridén-Saxin M, Pemberton N, Andersson Kda S, Dyrager C, Friberg A, Grøtli M, Luthman K. Fridén-Saxin M, et al. Among authors: dyrager c. J Org Chem. 2009 Apr 3;74(7):2755-9. doi: 10.1021/jo802783z. J Org Chem. 2009. PMID: 19323574

8

Inhibitors and promoters of tubulin polymerization: synthesis and biological evaluation of chalcones and related dienones as potential anticancer agents.

Dyrager C, Wickström M, Fridén-Saxin M, Friberg A, Dahlén K, Wallén EA, Gullbo J, Grøtli M, Luthman K. Dyrager C, et al. Bioorg Med Chem. 2011 Apr 15;19(8):2659-65. doi: 10.1016/j.bmc.2011.03.005. Epub 2011 Mar 10. Bioorg Med Chem. 2011. PMID: 21459004

9

2,6,8-Trisubstituted 3-hydroxychromone derivatives as fluorophores for live-cell imaging.

Dyrager C, Friberg A, Dahlén K, Fridén-Saxin M, Börjesson K, Wilhelmsson LM, Smedh M, Grøtli M, Luthman K. Dyrager C, et al. Chemistry. 2009 Sep 21;15(37):9417-23. doi: 10.1002/chem.200900279. Chemistry. 2009. PMID: 19670192

10

Alternative cytotoxic effects of the postulated IGF-IR inhibitor picropodophyllin in vitro.

Wu X, Sooman L, Wickström M, Fryknäs M, Dyrager C, Lennartsson J, Gullbo J. Wu X, et al. Among authors: dyrager c. Mol Cancer Ther. 2013 Aug;12(8):1526-36. doi: 10.1158/1535-7163.MCT-13-0091. Epub 2013 May 22. Mol Cancer Ther. 2013. PMID: 23699657

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters